{
  "pmcid": "10364767",
  "sha256": "08013e1b3b8da629bafcfc39b7a95efa263187ef7f89bfdcef2ddc549f76b3f6",
  "timestamp_utc": "2025-11-09T21:53:41.387853+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 15.009743589743593,
    "reading_ease": 14.166923076923098,
    "word_count": 195
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial of Antibiotics Versus Placebo for Uncomplicated Acute Appendicitis"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "double-blind, placebo-controlled, superiority randomised controlled trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "participants aged 18-60 years with uncomplicated acute appendicitis were randomised"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised 1:1 to receive either antibiotics (intravenous ertapenem followed by oral levofloxacin and metronidazole) or placebo"
      },
      "Objective": {
        "score": 1,
        "evidence": "aimed to evaluate the efficacy of antibiotics compared to placebo in adults with CT-confirmed uncomplicated acute appendicitis"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was treatment success, defined as resolution of appendicitis without appendicectomy within 10 days"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was stratified by centre, and allocation was concealed"
      },
      "Blinding": {
        "score": 2,
        "evidence": "Both patients and clinicians were blinded"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "From May 2017 to September 2020, 72 patients were randomised"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Six were excluded post-randomisation"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The treatment success rate was 97% (34/35) for antibiotics and 87% (27/31) for placebo, with a non-significant difference of 10% (90% CI -0.9 to 21; p = 0.142)"
      },
      "Harms": {
        "score": 1,
        "evidence": "No deaths occurred, and adverse events were similar between groups"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: EudraCT 2015-003634-26, NCT03234296"
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: Sigrid Jus√©lius Foundation, Academy of Finland, Mary and Georg C. Ehrnrooth Foundation"
      }
    },
    "total_score": 23,
    "max_score": 25
  }
}